IVF with Genetic Testing (PGT-A)
Pre Implantation Genetic Testing for Aneuploidy (PGT-A) allows us to screen embryos for abnormalities and identify those with the best chance of developing into a healthy baby.
Overview: IVF with Genetic Testing (PGT-A)
IVF with Genetic Testing (PGT-A) is widely considered to be the gold-standard IVF option for women over 35.
PGT-A is a highly specialised test that helps us to identify the “healthiest” embryos (i.e. the chromosomally normal embryos with a complete set of chromosomes) with the greatest potential for pregnancy success.
It may also be recommended for those who have had repeated miscarriages or failed IVF attempts.
PGT-A can be helpful for:
Woman Over 35 Years Of Age
The most common factor for difficulties conceiving is female age. This is due to the increased rate of chromosomal abnormalities in eggs (and subsequently embryos) as a woman’s maternal age increases.
By using PGT-A to screen the embryos, we can select the ones without chromosomal abnormalities for transfer.
This can significantly improve the chance of a successful pregnancy, especially for women over 35 years of age.
Repeated Miscarriages Or Failed IVF Treatments
One of the main reasons for miscarriage and IVF failure is chromosomal abnormality. PGT-A screens embryos to ensure they have the correct number of chromosomes.
By identifying the embryos without chromosomal abnormalities for transfer, we can reduce the risk of miscarriage and increase IVF success.
PGT-A testing has the potential to:
1. Greatly improve IVF birth rate per embryo transferred
2. Minimise the incidence of miscarriages
3. Minimise the incidence of a congenital condition at birth
4. Reduce the incidence of multiple pregnancies whilst maintaining a high live birth rate
Improving IVF Success Rates
With PGT-A, we can improve IVF success rates by identifying the chromosomally normal embryos for transfer.
This is significant because most chromosomally abnormal embryos will either miscarry or will fail to implant.
In fact, 40% to 75% of human embryos typically have chromosomal abnormalities, and this risk increases with maternal age.
Learn more about our (PGT-A) Success Rates HERE.
World Leaders In PGT-A
- CARE Fertility has pioneered Reproductive Genetic Testing for over 20 years.
- Our Clinic had the first PGT-A baby born in Ireland. An historic milestone.
- Our Successful Embryo Biopsy Rate is an outstanding *98.7%, positioning ourselves among the top percentile of clinics worldwide for successful biopsy rates.
(*Source: Cooper Surgical Genomics January 1, 2021-May 30, 2022)
What Sets Our Program Apart?
- Our PGT-A program pricing provides Genetic Analysis of up to eight embryos from one or more Egg Collections within a nine month period.
- Results from the Biopsies are provided after each egg collection.
- Our exceptional PGT-A Pregnancy Success Rates (Clinical Pregnancy) can be viewed HERE.
How is PGT-A Performed?
1. PGT-A is a highly specialised procedure whereby a few cells are removed from each embryo and sent to a genetics laboratory for testing.
2. The embryos are then frozen until the results are ready.
3. Once the results are received, the viable embryos (i.e. those without any chromosomal abnormalities) will then be considered for an embryo transfer, one at a time.
Our Successful Embryo Biopsy Rate is an exceptional and World-Leading *98.7% (*Source: Cooper Surgical Genomics).